 CAMBRIDGE, Mass., Jan. 03, 2023 GLOBE NEWSWIRE Agios Pharmaceuticals, Inc. Nasdaq: AGIO, a leader in the field of cellular metabolism pioneering therapies for rare diseases, today announced the grant of inducement equity awards outside of the Companys 2013 Stock Incentive Plan to its newly appointed Chief Commercial Officer, Tsveta Milanova. The grants were approved ... The post Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635c4 to Newly Appointed Chief Commercial Office... 